Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.21 USD | +2.46% | -2.37% | -22.49% |
Sales 2024 * | 599M 47.32B | Sales 2025 * | 767M 60.59B | Capitalization | 5.72B 452B |
---|---|---|---|---|---|
Net income 2024 * | -575M -45.44B | Net income 2025 * | -518M -40.93B | EV / Sales 2024 * | 8.6 x |
Net cash position 2024 * | 567M 44.81B | Net Debt 2025 * | 318M 25.13B | EV / Sales 2025 * | 7.87 x |
P/E ratio 2024 * |
-10.3
x | P/E ratio 2025 * |
-11.8
x | Employees | 927 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.13% |
Latest transcript on Ionis Pharmaceuticals, Inc.
1 day | -0.20% | ||
1 week | -2.37% | ||
Current month | -4.97% | ||
1 month | -5.63% | ||
3 months | -13.41% | ||
6 months | -21.22% | ||
Current year | -22.49% |
Managers | Title | Age | Since |
---|---|---|---|
D. Walke
FOU | Founder | 58 | 30/06/12 |
Brett Monia
FOU | Founder | 62 | 09/01/89 |
Elizabeth Hougen
DFI | Director of Finance/CFO | 62 | 30/04/00 |
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Loscalzo
CHM | Chairman | 72 | 02/02/14 |
Brett Monia
FOU | Founder | 62 | 09/01/89 |
Joan Herman
BRD | Director/Board Member | 70 | 09/06/19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
6.89% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
15/05/24 | 39.21 | +2.46% | 1,256,373 |
14/05/24 | 38.27 | -1.37% | 983,112 |
13/05/24 | 38.8 | -0.72% | 1,045,266 |
10/05/24 | 39.08 | -0.99% | 895,065 |
09/05/24 | 39.47 | -1.72% | 1,300,598 |
Delayed Quote Nasdaq, May 15, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.49% | 5.72B | |
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+50.13% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
+24.01% | 12.1B |
- Stock Market
- Equities
- IONS Stock